Policy & Regulation
ProtoKinetix AAGP Exhibits Efficacy and Safety in Model of Dry Eye Disease
8 April 2020 - - US-based clinical-stage biomedical company ProtoKinetix, Inc. (OTCQB: PKTX) having recently announced filing for patent protection for new applications of its AAGP (PKX-001) molecule,...
Lupus Therapeutics to start clinical study to assess hydroxychloroquine and/or other lupus therapies on COVID-19 in people with lupus
8 April 2020 - Lupus Therapeutics, the clinical trial affiliate of the Lupus Research Alliance, is starting a clinical study to assess the potential benefit of hydroxychloroquine and/or other lupus th...
CROMSOURCE starts first COVID-19 trial
8 April 2020 - CROMSOURCE, an Italy-based contract research organisation, has started its first COVID-19 trial on behalf of a European pharmaceutical company, it was reported on Tuesday.The trial is l...
Amgen partners with Adaptive Biotechnologies for COVID-19 prevention and treatment webinar
8 April 2020 - Human therapeutics company Amgen (NASDAQ:AMGN) and Adaptive Biotechnologies Corporation (NASDAQ:ADPT) on Tuesday jointly reported the launch of a webinar hosted by Bernstein on 8 April ...
Millendo Therapeutics Releases Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome
7 April 2020 - - US-based biopharmaceutical company Millendo Therapeutics, Inc. (NASDAQ: MLND) is discontinuing the development of livoletide as a potential treatment for Prader-Willi syndrome, t...
Alnylam, Dicerna form RNAi Therapeutics Collaboration on Alpha-1 Antitrypsin Deficiency-Associated
7 April 2020 - - US-based ribonucleic acid interference therapeutics specialists Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), and Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) have form...
Related Headlines

European Medicines Approves Cholesterol-Lowering Treatment Nilemdo and Its Combination with Ezetimibe Nustendi

HEMA Biologics wins FDA approval of SEVENFACT for treating adult Hemophilia A and B patients with inhibitors

MBio partners with DARPA to seek FDA approval of LightDeck Platform in identifying highly contagious individuals early

US FDA receives INOVIO Pharmaceuticals' Investigational New Drug application for INO-4800

The international iReceptor Plus consortium to launch technology tools and infrastructure to aid COVID-19 treatment

Boston Biomedical doses first patient in phase one study assessing TP-3654

RTI International completes acquisition of Medical Data Analytics

US Food and Drug Administration Approves Reblozyl to Treat Anemia in Adults with Lower-Risk Myelodysplastic Syndromes

Applied Biology to introduce COVID-19 drug discovery platform in collaboration with Brown University

Ortho Clinical Diagnostics to launch COVID-19 Antibody Test

OxThera concludes recruitment in Phase 3 ePHex Oxabac study in primary hyperoxaluria patients

UroGen Shows Positive Interim Data from Phase 2b Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer

Spectrum Solutions Claims Saliva Collection Device Answers Critical Testing Hurdles

Pear Therapeutics Presents Data at ASAM Virtual 2020 Program Demonstrating High Satisfaction and Engagement for reSET and reSET-O in Treating Substance Use Disorder and Opioid Use Disorder

Organizations Rising to the Challenge of COVID-19 Communications, but Needs Persist, Study Finds